TRACON Pharmaceuticals Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. TRACON Pharmaceuticals latest Real Value cannot be determined due to lack of data. The recent price of TRACON Pharmaceuticals is $0.0. Our model measures the value of TRACON Pharmaceuticals from inspecting the company fundamentals such as current valuation of (2.64 M), and Return On Equity of -12.77 as well as reviewing its technical indicators and probability of bankruptcy. . In general, most investors recommend obtaining undervalued equities and abandoning overvalued equities since, at some point future time, asset prices and their ongoing real values will merge together.
TRACON Pharmaceuticals Total Value Analysis
TRACON Pharmaceuticals is at this time estimated to have valuation of (2.64 M) with market capitalization of 3.83 M, debt of 968 K, and cash on hands of 13.58 M. The negative valuation of TRACON Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the TRACON Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(2.64 M) | 3.83 M | 968 K | 13.58 M |
TRACON Pharmaceuticals Investor Information
The company recorded earning per share (EPS) of 106.4. TRACON Pharmaceuticals last dividend was issued on the 8th of November 2019. The entity had 1:20 split on the 10th of April 2024. Based on the key indicators related to TRACON Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, TRACON Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.TRACON Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. TRACON Pharmaceuticals has an asset utilization ratio of 119.2 percent. This suggests that the OTC Stock is making $1.19 for each dollar of assets. An increasing asset utilization means that TRACON Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.TRACON Pharmaceuticals Ownership Allocation
Almost 86.38 % of TRACON Pharmaceuticals outstanding shares are held by general public with 2.2 percent owned by insiders and only 11.42 (percent) by institutions.TRACON Pharmaceuticals Profitability Analysis
The company reported the previous year's revenue of 12.04 M. Net Loss for the year was (3.59 M) with loss before overhead, payroll, taxes, and interest of (13.89 M).TRACON Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 32.7 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in TRACON OTC Stock
If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |